Alan Meds Semaglutide Cost: BOGO Offer vs Monthly Pricing Compared

Last reviewed: September 5, 2026 Last updated: September 5, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance. His work has included scaling healthcare startups, leading CLIA lab integrations, and helping expand consumer access to precision health tools.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

PlexusDx publishes this comparison and is one of the providers discussed. We use the same evidence rules for our own program and competing programs.

The short answer

Alan Meds presents two different pricing structures for compounded semaglutide on its official pages, both captured September 4, 2026. The first is a buy-one-get-one promotional offer: $315 upfront for two months, working out to $157.50 per month if the two-month cycle renews at the same rate. The second is an older first-month-then-refill model: $297 for the first month, then $397 per month for refills. Alan Meds has not clarified which structure is current or how the BOGO offer renews, so readers should confirm pricing at checkout.

PlexusDx charges $189 per month for compounded semaglutide injection on a month-to-month plan with no membership fee, or $149 per month on a six-month prepaid commitment. Over 12 months, PlexusDx's six-month plan costs $1,788 total—lower than Alan Meds' BOGO model if that model renews at $315 per two-month cycle ($1,890 total), and substantially lower than the older first-month/refill structure ($4,664 total). PlexusDx holds the same price at every dose and publishes a 4.2-star Trustpilot rating with 81% of reviews at four stars or higher (captured September 4, 2026). Alan Meds includes consultation, medication, and shipping with no membership fee, but the conflicting official pricing and unclear renewal terms make cost planning difficult.

Compounded medication disclosure: Compounded medications are not FDA-approved. FDA does not review compounded drugs before marketing for safety, effectiveness, or quality. A licensed clinician determines whether a prescription is appropriate for an individual patient. PlexusDx works with licensed 503A compounding pharmacies.

At-a-glance comparison

Pricing structures normalized: BOGO, refill model, and flat-rate plans

Alan Meds' official pages show two distinct pricing models for compounded semaglutide injection, both captured September 4, 2026. The first is a buy-one-get-one promotional offer in which a customer pays $315 upfront and receives two months of medication—working out to $157.50 per month if that two-month cycle continues to renew at the same rate. The second is an older first-month-then-refill structure: $297 for the initial month, then $397 per month thereafter. Alan Meds has not clarified which model is current, whether the BOGO offer renews at $315 per two-month cycle, or whether customers on the BOGO plan eventually migrate to a different rate. We recommend confirming pricing and renewal terms at checkout before committing.

PlexusDx offers compounded semaglutide injection at a flat rate that does not change by dose. The month-to-month plan costs $189 per month with no commitment; a six-month prepaid plan reduces the rate to $149 per month. Both plans include the provider visit, medication, and shipping, and neither charges a membership fee.

12-month cost comparison (our calculations)

To compare introductory offers against ongoing costs, we normalize each plan to a 12-month horizon. These figures are our calculations based on the pricing structures observed; readers should verify current rates and renewal terms directly with each provider.

If Alan Meds' BOGO offer renews indefinitely at $315 per two-month cycle, the 12-month cost would be $1,890—$102 more than PlexusDx's six-month prepaid plan but $378 less than PlexusDx's month-to-month plan. However, Alan Meds has not documented the BOGO renewal terms, so the actual cost over 12 months remains uncertain. The older first-month/refill model costs $4,664 over 12 months—more than double any other option in this comparison.

Decision factors: transparency, commitment, and renewal risk

Pricing transparency and consistency

PlexusDx publishes a single, consistent pricing structure: $189 per month on a month-to-month plan or $149 per month on a six-month prepaid plan. The rate does not change by dose, and there are no introductory rates that later revert to higher refill prices. Alan Meds presents two conflicting models on official pages captured the same day—one a BOGO promotional offer, the other a first-month/refill structure—without clarifying which is current or how the BOGO offer renews. This makes 12-month cost planning difficult until a customer confirms terms at checkout.

Upfront commitment and flexibility

Alan Meds' BOGO offer requires $315 upfront for two months. If the offer is renewable at the same rate, the effective monthly cost may be lower than PlexusDx's month-to-month plan, but the customer must prepay in two-month blocks. PlexusDx's month-to-month plan requires no commitment and bills $189 per month; customers who prefer to prepay can choose the six-month plan at $149 per month. Both PlexusDx plans charge the same flat rate at every dose, so there are no mid-treatment price increases as dosage titrates.

Review record and service history

PlexusDx holds a 4.2-star rating on Trustpilot, with 76% of reviews at five stars and 81% at four stars or higher (captured September 4, 2026). Alan Meds' review rating and volume were not captured in the research pass, so we cannot compare reported customer experience or support responsiveness between the two providers.

Medication type and regulatory status

Both Alan Meds and PlexusDx offer compounded semaglutide injection prepared by licensed compounding pharmacies. Compounded medications are not FDA-approved. FDA does not review compounded drugs before marketing for safety, effectiveness, or quality. A licensed clinician determines whether a prescription is appropriate for an individual patient. PlexusDx works with licensed 503A compounding pharmacies.

Choose Alan Meds if…

You confirm at checkout that the BOGO offer renews indefinitely at $315 per two-month cycle, you are comfortable prepaying in two-month blocks, and you verify that the effective monthly rate remains lower than alternative options over your intended treatment duration. Alan Meds includes consultation, medication, and shipping with no membership fee, and the BOGO structure may offer savings if the renewal terms align with your commitment preference.

Where PlexusDx fits

PlexusDx is the simpler choice for customers who value transparent, consistent pricing and want to avoid introductory-rate-to-refill jumps or unclear renewal terms. The month-to-month plan at $189 per month requires no commitment and no upfront block payment. The six-month prepaid plan at $149 per month delivers the lowest 12-month total cost in this comparison ($1,788) and locks in a flat rate for six months at a time. Both plans hold the same price at every dose, so titration never triggers a price increase. PlexusDx publishes a 4.2-star Trustpilot rating with the majority of reviews at four or five stars, and every customer completes a brief intake reviewed by a licensed provider before any charge is authorized.

Methodology and freshness

All Alan Meds pricing was captured from official company pages on September 4, 2026. We observed two distinct pricing models for compounded semaglutide injection on the same date: a buy-one-get-one promotional offer ($315 upfront for two months) and an older first-month-then-refill model ($297 first month, $397 refill). Alan Meds has not clarified which structure is current or how the BOGO offer renews; readers should verify pricing and renewal terms at checkout. PlexusDx pricing was captured between July 17 and July 23, 2026, and review data was captured September 4, 2026. The 12-month cost figures in this article are our calculations based on the pricing structures observed; we label prepaid per-month equivalents as prepaid and note when renewal terms are unconfirmed. No payment was submitted to either provider during the research pass.

Frequently Asked Questions

Does Alan Meds' BOGO offer renew at the same rate?

Alan Meds has not documented whether the $315 two-month BOGO offer renews indefinitely at the same rate or eventually reverts to a different pricing structure. Customers should confirm renewal terms at checkout before committing to the promotional offer.

Which pricing model does Alan Meds currently use for semaglutide?

Alan Meds' official pages showed two different pricing models for compounded semaglutide on September 4, 2026: a $315 two-month BOGO offer and an older $297 first-month then $397 refill structure. The company has not clarified which is current, so confirm pricing directly during checkout.

Does PlexusDx charge more as my semaglutide dose increases?

No. PlexusDx holds the same monthly price at every dose for compounded semaglutide injection: $189 on the month-to-month plan or $149 on the six-month prepaid plan. Dose titration does not trigger a price increase.

What is included in PlexusDx's semaglutide injection price?

The monthly price includes the licensed provider visit, compounded semaglutide injection, and shipping. PlexusDx charges no membership fee, no consultation fee, and no per-dose surcharge. You pay one flat rate each month or prepay for six months at a lower rate.

Are compounded semaglutide medications FDA-approved?

No. Compounded medications are not FDA-approved. FDA does not review compounded drugs before marketing for safety, effectiveness, or quality. A licensed clinician determines whether a prescription is appropriate for an individual patient based on your medical history and current health status.

Sources

• PlexusDx official product pages for compounded semaglutide injection, pricing captured July 17–23, 2026; review data captured September 4, 2026
• Alan Meds official medication pages (alanmeds.com/medications/personalized-compounded-semaglutide and alanmeds.com/resource/tirzepatide-supply-update), pricing and service details captured September 4, 2026
• Trustpilot profile for PlexusDx, rating and review distribution captured September 4, 2026

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance. References are included at the end of the article when scientific, medical, or health-related claims are discussed.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.